Garbage in, garbage out. Or rather more felicitously: the tree of nonsense is watered with error, and from its branches swing the pumpkins of disaster.
I
n his 1904 publication on the preventive effect of serum inoculations against enteric fever, Karl Pearson was likely the first medical researcher to report the use of formal techniques to combine data from different studies. 1, 2 However, it was not until 1976 that the psychologist Gene Glass coined the term "meta-analysis" in his article entitled "Primary, Secondary and Meta-analysis of Research" 1, 3 -in which he defined it as, "Meta-analysis refers to the analysis of analyses. I use it to refer to the statistical analysis of a large collection of results from individual studies for the purpose of integrating findings."
There is a continued mandate for practicing evidencebased medicine and its prerequisite rigorous analysis of the comparative effectiveness of alternative diagnostics and treatments. 4 This is borne out by a recently published evidence-based medicine "manifesto for better health care"-written in response to perceived systematic bias, waste, error, and fraud in research underpinning patient care. 5 Moreover, clinicians encounter an ever increasing and frequently overwhelming amount of information, even in a narrow scope or area of interest. 6 Given this enormous amount of scientific information published every year, systematic reviews and meta-analyses have become indispensable methods for the evaluation of medical treatments and the delivery of evidence-based best practice. 7 The present basic statistical tutorial thus focuses on the fundamentals of a systematic review and meta-analysis, against the backdrop of practicing evidence-based medicine. 4 This tutorial is not intended to provide in-depth coverage of how to actually perform a systematic review or meta-analysis [8] [9] [10] [11] but instead to familiarize the reader-as a consumer of these methodologies-with these specific concepts, techniques, and steps ( Clinicians encounter an ever increasing and frequently overwhelming amount of information, even in a narrow scope or area of interest. Given this enormous amount of scientific information published every year, systematic reviews and meta-analyses have become indispensable methods for the evaluation of medical treatments and the delivery of evidence-based best practice. The present basic statistical tutorial thus focuses on the fundamentals of a systematic review and meta-analysis, against the backdrop of practicing evidence-based medicine. Even if properly performed, a single study is no more than tentative evidence, which needs to be confirmed by additional, independent research. A systematic review summarizes the existing, published research on a particular topic, in a well-described, methodical, rigorous, and reproducible (hence "systematic") manner. A systematic review typically includes a greater range of patients than any single study, thus strengthening the external validity or generalizability of its findings and the utility to the clinician seeking to practice evidence-based medicine. A systematic review often forms the basis for a concomitant meta-analysis, in which the results from the identified series of separate studies are aggregated and statistical pooling is performed. This allows for a single best estimate of the effect or association. A conjoint systematic review and metaanalysis can provide an estimate of therapeutic efficacy, prognosis, or diagnostic test accuracy. By aggregating and pooling the data derived from a systemic review, a well-done meta-analysis essentially increases the precision and the certainty of the statistical inference. The resulting single best estimate of effect or association facilitates clinical decision making and practicing evidence-based medicine. A well-designed systematic review and meta-analysis can provide valuable information for researchers, policymakers, and clinicians. However, there are many critical caveats in performing and interpreting them, and thus, like the individual research studies on which they are based, there are many ways in which meta-analyses can yield misleading information. Creators, reviewers, and consumers alike of systematic reviews and meta-analyses would thus be well-served to observe and mitigate their associated caveats and potential pitfalls. (Anesth Analg 2019;128:575-83)
Most research in anesthesia, perioperative medicine, critical care, and pain medicine relies on inferential statistics. Inferential statistics allows researchers to make a valid inference about an association of interest for a specific population that is based on data collected from a random sample of that population. An unknown population parameter representing the clinical association or treatment effect of interest can thus be estimated from the study sample. 13, 14 For example, in a randomized controlled trial, the statistical analysis of the descriptive data from a random sample of patients is used to make inferences and conclusions about the larger population and thus similar future patients. 15 Based on a sample of data that are randomly collected at a given point in time, an estimated value is generated. Such a sample point estimate is a single value that can be used to validly estimate the corresponding population parameter. A series of repeated, random (unbiased) samples of data collected from the same underlying population would be expected to generate different yet equally valid point estimates of the corresponding population parameter. 15 
Confidence Intervals
Formally, a confidence interval (CI) is an interval of values that contains the true population parameter in a fixed percentage of samples with repeated sampling. This fixed percentage is termed the confidence level, which is often, though arbitrarily, chosen as 95%. 16 This means that when distinct samples of the same size are repeatedly taken from the same population, and if one calculates the 95% CI for each sample, about 95% of them will contain the true population parameter. [16] [17] [18] The width of a CI is inversely related to sample size, such that studies with a larger number of subjects usually provide more precise estimates than smaller sample studies. Hence, a larger sample size is usually more robust. However, this is not always the case because the width of the CI also depends on the variability of the sample data. 16, 19 The choice of the confidence level likewise affects the width of the CI because the CI widens when the confidence level increases. Thus a 99% CI provides a higher confidence of including the true population parameter value than a 95% CI or 90% CI, but the 95% CI will have a wider total range of values. [16] [17] [18] [19] Systematic Review Versus a Narrative Review A systematic review summarizes the existing, published research on a particular topic, in a well-described, methodical, rigorous, reproducible, and hence "systematic" manner. 12, 20 For example, Sondekoppam and Tsui 21 performed a systematic review of the factors associated with the risk of neurological complications after peripheral nerve blocks. Lam et al 22 performed a systematic review of the association between perioperative sleep-disordered breathing and postoperative delirium and cognitive impairment.
Operationally, a systematic review (1) addresses a specific clinical question; (2) requires a comprehensive literature search; (3) uses explicit selection criteria to identify relevant published studies; (4) assesses the methodological quality of the included studies; (5) explores the differences among study results; and (6) either qualitatively or quantitatively synthesizes the study results. 23 As compared to a systematic review, a narrative review typically (1) addresses various aspects of the disease or clinical condition, including its etiology, diagnosis, prognosis, and/or treatment; (2) provides no explicit literature search or published study inclusion criteria; (3) does not assess the risk of bias in the cited primary studies; and (4) does not report quantitative point estimates and their CIs. 20 A well-written narrative review can offer the reader a contemporary, comprehensive overview of a disease or clinical condition. 12, 20 For example, Sekandarzad et al 24 authored a narrative review of perioperative anesthesia care and tumor progression. Gamez and Habib 25 authored a narrative review of predicting the severity of acute pain after cesarean delivery.
However, a narrative review of the ostensibly most relevant published studies can suffer from subjectivity and bias in the authors' literature selection process. 12, 26 Unlike a systematic review, a narrative review is not expected to provide a reliable and valid (unbiased) answer to a focused clinical question. 20 
Meta-analysis
A systematic review can and often does serve as the basis for a concomitant meta-analysis, in which the results from the identified series of separate primary studies are aggregated and statistical pooling is performed. Assuming both the systematic review and meta-analysis are done well, this allows for a single best estimate of the clinical effect or association. 20 For example, Barile et al 27 undertook a meta-analysis of the association between acute normovolemic hemodilution and allogeneic red blood cell transfusion in cardiac surgery. Wu et al 28 undertook a meta-analysis of the administration of hypertonic solutions for hemorrhagic shock.
The scientific rigor of a systematic review and conjoint meta-analysis 26, 29 is basically predicated on the following:
• A clearly defined prior hypothesis • A thorough search of existing trials and studies • Strict inclusion criteria for trials and studies • Uniform guidelines for data analysis
Assessing for the potential pitfalls with a meta-analysis 26 includes:
• Checking for heterogeneity • Checking for publication bias • Checking robustness of the findings
RATIONALE FOR A SYSTEMATIC REVIEW AND META-ANALYSIS
Even if properly performed, a single study is no more than tentative evidence, which needs to be confirmed by additional, independent research. 26 Furthermore, an individual research study may not be representative of the total corpus of the published literature and available evidence, and its results hence may be inadvertently misleading. 20 In contrast, a systematic review typically includes a greater range of types of patients (eg, age, gender, race/ethnicity, nationality) than any single study, thus strengthening the external validity or generalizability of its findings and the utility to the clinician seeking to practice evidence-based medicine. 20 A systematic review, with or without meta-analysis, offers a more objective appraisal of the available evidence than a traditional narrative review. 30 A conjoint systematic review and meta-analysis can provide an estimate of therapeutic efficacy, prognosis, or diagnostic test accuracy. 12, 20 By aggregating and pooling the data derived from a systemic review, a meta-analysis essentially increases the precision and the certainty of the statistical inference-by increasing the total sample size and thus usually generating a narrower, aggregated CI. 20, 26 However, when conducting, as is usually appropriate, a random effects meta-analysis, variability among the estimated treatment effects in the included studies (ie, the presence of heterogeneity) may result in a wider CI for the aggregated data than for any of the individual studies. 31 Nevertheless, the resulting single best estimate of effect or association facilitates clinical decision making and practicing evidence-based medicine. 20, 26 
LITERATURE SEARCH STRATEGY AND STUDY INCLUSION ALGORITHM
Given its principal goal, the applied literature search strategy and study inclusion algorithm are the cornerstones of a valid systematic review.
Most systematic reviews rely chiefly on searching multiple electronic online databases of the published literature, among them MEDLINE (National Library of Medicine, Bethesda, MD), Embase (Elsevier, Amsterdam, the Netherlands), Cochrane Database of Systematic Reviews (Cochrane Collaboration, London, United Kingdom), Web of Science (Clarivate Analytics, Philadelphia, PA), and SCOPUS (Elsevier, Amsterdam, the Netherlands).
12,20 These searches are facilitated by the use of the applicable terms from Medical Subject Headings (MeSH), which is the controlled vocabulary thesaurus, used by the National Library of Medicine for indexing articles. 12, 20 Other important sources include the US Food and Drug Administration reviews of new drug applications, recently published abstracts presented at scientific meetings, other recent review articles, and textbook reference lists. 12, 20 The initial search process invariably generates a very large cohort of studies for potential inclusion, but usually only a small proportion of these studies are selected from this vast number of publications on the topic. 12 After casting an initially broad net, the next crucial step is determining whether a given study should be included in the systematic review. Here is where subjectivity and bias-similar to that possible with a narrative review of a topic-can occur in the authors' study selection process. This risk is mitigated by 2 investigators independently reviewing each located study article, using a clearly defined set of inclusion and exclusion criteria. 12 The details of this intensive effort are reported as a flowchart in an article with a systematic review. 12 In their systematic review and meta-analysis of safety and efficacy of volatile anesthetic agents compared with standard IV midazolam/ propofol sedation in ventilated critical care patients, Jerath et al 32 present such a flowchart depicting their applied literature search strategy and study inclusion algorithm (Figure 2 ).
ASSESSING THE SCIENTIFIC QUALITY OF THE INCLUDED STUDIES
The scientific quality of included trials is of obvious importance to meta-analysis. If the primary, raw material incorporated is flawed, then the conclusions of a meta-analytic study will be equally invalid. 33 Although widely recommended, the method of assessing the quality of the incorporated clinical trials has historically been a subject of major controversy and debate. 33, 34 This has been compounded by the plethora of available such instruments, and moreover, by most of these scoring systems lacking a focused theoretical basis and clear objectives. 33 The scales differ considerably in terms of dimensions covered, size and complexity, and the weight assigned to the key domains most relevant to the vital control of biasnamely, randomization, blinding, and withdrawals. 33, 35 www.anesthesia-analgesia.org
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The Jadad scale assesses the methodological quality of a randomized controlled trial. 12 The original Jadad scale and score 36, 37 has been modified; however, the items on the Jadad scale continue to address the presence of a description and the methodological rigor of random allocation, allocation concealment, blinding, and withdrawals and dropouts, with a scoring range of 0-5. 38 In their systematic review and meta-analysis of the effect of preoperative gabapentin on postoperative nausea and vomiting, Grant et al 39 assessed the quality of the included randomized controlled trials using the Jadad scale and their individual Jadad scores.
The Cochrane Collaboration risk of bias tool 40,41 assesses the following study design quality domains: generation of the allocation sequence; allocation concealment; blinding of investigators and participants; blinding of outcome assessors; incomplete outcome data; selective outcome reporting; and any other important concerns about bias. Each item is classified as low, unclear, or high risk of bias. A decision to classify the overall risk of bias as low, unclear, or high is made by ≥2 independent reviewers. 40, 41 In their systematic review and meta-analysis of the effects of epidural labor analgesia with low concentrations of local anesthetics on obstetric outcomes, Wang et al 42 applied the Cochrane Collaboration risk of bias tool (Figure 3) . Grading of Recommendations, Assessment, Development and Evaluations is a transparent framework for developing and presenting summaries of evidence and provides a systematic approach for making clinical practice recommendations. 43, 44 Grading of Recommendations, Assessment, Development and Evaluations is the most widely adopted tool for grading the quality of evidence and for making recommendations. A 20-part series of articles was published between 2011 and 2018 in Journal of Clinical Epidemiology, providing extensive guidance for the use of Grading of Recommendations, Assessment, Development and Evaluations methodology. 45 
SUMMARIZING THE FINDINGS OF A SYSTEMATIC REVIEW AND META-ANALYSIS
After completing their systematic review of the literature, the authors may appropriately conclude that combining the results from the individual primary studies to generate a single estimate of effect or association is not appropriatemost commonly because of excess variability or heterogeneity (ie, lack of consistency in design and/or results) among the discovered studies (see further description below). The systematic review will then conclude with a table or tables simply presenting the results of its individual primary studies. 12, 46 Alternatively, there is adequate consistency in the design and results among the primary studies to proceed with a meta-analysis, in which a summary or pooled ("best") estimate of the effect or association is generated from the weighted results of the individual primary studies.
12,46

Forest Plot of Individual Included Studies
The results of a conventional meta-analysis are typically displayed as a so-called forest plot. 12, 46, 47 This forest plot shows the originally reported point estimate of the effect or association from each included primary study. These individual point estimates are presented as a square, whose size is proportional to the relative sample size and weight of each study. The CI for each point estimate is presented as an overlying horizontal line. The no effect or null effect value is shown as a solid vertical line, for example, at 1.0 for a relative risk or an odds ratio or at zero for difference in means. 12, 46, 47 The origin of the term "forest plot" is uncertain; however, it has been variously attributed to a researcher's name or its appearance resembling a "forest of trees." 12, 48 While some experts believe that it ultimately helps the reader "see the forest and the trees," 12 this author opines that it resembles his long-ago childhood, cut-out Christmas tree.
Pooled Point Estimate From Included Studies
The combined or pooled estimate of the effect or association is conventionally presented as a diamond, with its width representing the range of the CI for this combined or pooled estimate. A dashed vertical line is centered on this combined summary estimate. 46 As any CI widens, uncertainty about the magnitude of the effect increases. When the CI for the combined or pooled estimate crosses the null effect value (eg, a relative risk or odds ratio of 1.0), the intervention may have no effect at all. 46 In their systematic review and meta-analysis of targeted temperature management after cardiac arrest, Kalra et al 49 generated and reported a series of forest plots with corresponding pooled point estimates (Figure 4) .
ASSESSING THE HETEROGENEITY OF ORIGINAL STUDIES
The main and often vexing problem with meta-analysis is the "apples and oranges" question: how similar must the studies be such that a meta-analytic combination is valid and meaningful?
7 Potentially important differences in the individual studies considered for a meta-analysis are referred to as heterogeneity. Two domains are commonly included in the assessment of such heterogeneity: (1) the design of the original studies; and (2) the results of the original studies. 50 
Assessing Qualitative Heterogeneity of the Design of the Original Studies
The 4 key elements in assessing the qualitative heterogeneity of the design of the original studies incorporated into a metaanalysis 50 are summarized by the Cochrane Collaboration acronym or mnemonic, PICO: Patient, Problem or Population; Intervention; Comparison, Control or Comparator; and Outcomes. 12, 20, 51, 52 Two additional elements can be added to create PICOTS: follow-up time (T) and the type of study design (S) (eg, randomized controlled trial, nonrandomized controlled trial, cohort study). 12, 53, 54 This descriptive, qualitative study design information is typically presented in the initial table in the systematic review and meta-analysis article.
Combining the results from multiple studies is appropriate when the underlying pathophysiology and epidemiology are such that across the range of patients, interventions, outcomes, and study methodologies, one can anticipate more or less the same magnitude of treatment effect or association. 50 There are 3 specific questions concerning eligibility criteria and appropriateness for inclusion in a systematic review, 20 namely:
• Are results likely to be similar across the range of included patients? • Are results likely to be similar across the range of studied interventions or exposures? • Are results likely to be similar across the range of ways the outcome was measured?
Assessing Quantitative Heterogeneity of the Results of the Original Studies
There are 2 criteria for not combining the results of original studies in a meta-analysis: (1) traditional hypothesis test for heterogeneity. The I 2 statistic generates an estimated percentage of the variability in the results across studies that is likely due to true differences in the treatment effect versus simply chance. 46, 50 Because the I 2 statistic focuses on the magnitude of variability instead of the statistical significance of the variability, it is the preferred method for assessing for heterogeneity in the results across primary studies included in a meta-analysis. 46, 55 As the I 2 statistic increases, the observed variability being due to other than simply chance becomes more likely. Conventionally, an I 2 statistic of <0.25 (25%) characterizes low heterogeneity, 0.25 (25%) to 0.5 (50%) as moderate heterogeneity, and >0.5 (50%) as high heterogeneity. 50 A 95% CI can be generated for the I 2 statistic, and in a meta-analysis with a limited number of small-scale included studies, this CI can be quite wide, necessitating caution in making a strong inference about heterogeneity. 46, 56 
ASSESSING FOR PUBLICATION BIAS
Publication bias is the tendency for positive studies-those finding and reporting a clinically or statistically significant Figure 4 . Examples of forest plot and pooled point estimate from the systematic review and meta-analysis by Kalra et al. 49 A, Forest plot comparing all-cause mortality between hypothermia and normothermia. B, Forest plot comparing favorable neurological outcome between hypothermia and normothermia. The blue diamond depicts the point estimate and its 95% CI. The red dotted lines represent a random effects generated overall estimate. HT indicates hypothermia; NT, normothermia; RR, relative risk. Figure reprinted with permission from Anesth Analg. 2018;126:867-875. 49 effect or association with the intervention-to be more likely published. 12 The basis for this phenomenon is multifactorial. It includes the researchers being less inclined to complete and to submit negative findings to journals; journal peer reviewers less likely to find negative studies novel and interesting; and journal editors less motivated to publish them. 12 The onus is thus on authors of systematic reviews to make a concerted effort to find such negative, often unpublished studies. This is aided by the presence of public clinical trial registries and the obligation of investigators to register their trials before patient enrollment. 12 
Funnel Plot
A funnel plot is a graphical method for detecting the downstream effect of publication bias in the selection process of studies in a systematic review and meta-analysis. For each included study, the magnitude of the effect size is plotted on the horizontal x-axis against a measure of the size or precision of the study, for instance, the sample size, number of outcome events, SE, or CI on the horizontal y-axis. 12, 46, 57 Larger and more precise studies are plotted at the top of the graph and are typically closely grouped around the pooled estimate of the true effect or association. Smaller and less precise studies are plotted at the lower part of the graph and more widely dispersed around the pooled estimate of the true effect or association. In the absence of publication bias, the distribution of individual point estimates should be symmetric. The resulting graphical display should thus resemble an inverted funnel. If visual inspection of the funnel plot does not identify a skewed or asymmetrical shape, authors can conclude that there was little evidence of publication bias. 12, 46 Statistical tests can also be used to assess for presence of publication bias. 58, 59 Heesen et al 60 used a funnel plot to assess for publication bias in their systematic review and meta-analysis of prevention of spinal anesthesia-induced hypotension during cesarean delivery by 5-hydroxytryptamine-3 receptor antagonists ( Figure 5 ).
UTILITY OF FINDINGS
Smaller scale meta-analyses-arbitrarily, those with <200 total outcome events-may only be useful for summarizing the available information and generating hypotheses for future research. The results of such smaller meta-analyses should be viewed with caution, even if the associated P value indicates extreme statistical significance. 61 Larger meta-analyses-those with >200 total outcome events-are likely to be more valid and reliable, and thus assuredly clinically applicable. 61 A well-conducted meta-analysis of a series of large trials (with their individual patient data) may provide the most robust estimate of the treatment effect in the overall patient cohort and in clinically important subgroups. 61 
CONCLUSIONS
As noted in 1999 by Isaacs and Fitzgerald, 62 in their satirical article entitled "Seven Alternatives to Evidence Based Medicine": "Clinical decisions should, as far as possible, be evidence based. So runs the current clinical dogma. We are urged to lump all the relevant randomized controlled trials into one giant meta-analysis and come out with a combined odds ratio for all decisions. Physicians, surgeons, nurses are doing it; soon even the lawyers will be using evidence based practice. But what if there is no evidence on which to base a clinical decision?" Now 20 years later, there remains a marked predilection-some might even say, a proverbial scientific Figure 5 . Example of a funnel plot to assess for publication bias a systematic review and meta-analysis by Heesen et al. 60 Figure reprinted with permission from Anesth Analg. 2016;123:977-988. 60 intoxication-for performing and reporting systematic reviews and meta-analyses. A well-designed systematic review and meta-analysis can provide valuable information for researchers, policymakers, and clinicians.
However, there are many critical caveats in performing and interpreting them, and thus, like the individual research studies on which they are based, there are many ways in which meta-analyses can yield misleading information. 6 Ergo, as recently opined, "Meta-analyses, the Pinnacle of Science or an Error-Ridden Exercise." 26 Creators, reviewers, and consumers alike of systematic reviews and meta-analyses would thus be well-served to observe the Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement, [63] [64] [65] [66] and consider applying A MeaSurement Tool to Assess systematic Reviews 67, 68 -"How to Tell the Good From the Bad and the Ugly." 69 E DISCLOSURES Name: Thomas R. Vetter, MD, MPH.
